Literature DB >> 2334394

Reversible cell damage by T-cell perforins. Calcium influx and propidium iodide uptake into K562 cells in the absence of lysis.

J Jones1, M B Hallett, B P Morgan.   

Abstract

The non-lethal effects of the lymphocyte-derived pore-forming toxin perforin on the human erythroleukaemia cell line K562 were investigated. By using the fluorescent Ca2+ indicator fura-2, perforin was shown to cause intracellular Ca2+ concentration to rise transiently into the micromolar range in the absence of cell death. By fluorescence-activated cell sorting it was demonstrated that K562 cells took up the membrane-impermeant nuclear stain propidium iodide (PI) when exposed to non-lethal doses of perforin. The permeability to PI was short-lived, confirming the transience of the perforin pore. Analogies with non-lethal effects and recovery processes occurring in nucleated cells exposed to the membrane-attack complex of complement are drawn.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334394      PMCID: PMC1131287          DOI: 10.1042/bj2670303

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Cell damage by cytolysin. Spontaneous recovery and reversible inhibition by divalent cations.

Authors:  C L Bashford; G Menestrina; P A Henkart; C A Pasternak
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

2.  Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity.

Authors:  J D Young; H Hengartner; E R Podack; Z A Cohn
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  Mechanism of cytotoxicity of human large granular lymphocytes: relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complement.

Authors:  L S Zalman; M A Brothers; F J Chiu; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  The membrane attack complex of complement induces permeability changes via thresholds in individual cells.

Authors:  A K Patel; A K Campbell
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

5.  Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis.

Authors:  B P Morgan; J R Dankert; A F Esser
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

6.  Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.

Authors:  D F Carney; C H Hammer; M L Shin
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

7.  Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.

Authors:  D F Carney; C L Koski; M L Shin
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

8.  Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack.

Authors:  A K Campbell; B P Morgan
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

9.  The use of fura-2 to determine the relationship between cytoplasmic free Ca2+ and oxidase activation in rat neutrophils.

Authors:  F A Al-Mohanna; M B Hallett
Journal:  Cell Calcium       Date:  1988-02       Impact factor: 6.817

10.  Sequential activation and lethal hit measured by [Ca2+]i in individual cytolytic T cells and targets.

Authors:  M Poenie; R Y Tsien; A M Schmitt-Verhulst
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

View more
  12 in total

1.  Imaging Ca2+ changes in individual oligodendrocytes attacked by T-cell perforin.

Authors:  J Jones; S Frith; S Piddlesden; B P Morgan; D A Compston; A K Campbell; M B Hallett
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

2.  Killing of cells by perforin. Resistance to killing is not due to diminished binding of perforin to the cell membrane.

Authors:  J Jones; B P Morgan
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

3.  Necrosis and apoptosis associated with distinct Ca2+ response patterns in target cells attacked by human natural killer cells.

Authors:  Y Oshimi; K Oshimi; S Miyazaki
Journal:  J Physiol       Date:  1996-09-01       Impact factor: 5.182

4.  Target cell death triggered by cytotoxic T lymphocytes: a target cell mutant distinguishes passive pore formation and active cell suicide mechanisms.

Authors:  D S Ucker; J D Wilson; L D Hebshi
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

Review 5.  Rheumatoid arthritis and citrullination.

Authors:  Erika Darrah; Felipe Andrade
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

6.  Membrane attack complex (MAC)-mediated damage to spermatozoa: protection of the cells by the presence on their membranes of MAC inhibitory proteins.

Authors:  I A Rooney; A Davies; B P Morgan
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

7.  Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells.

Authors:  C M Sanderson; J E Parkinson; M Hollinshead; G L Smith
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target.

Authors:  W K Nishioka; R M Welsh
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

9.  Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.

Authors:  S Meri; B P Morgan; M Wing; J Jones; A Davies; E Podack; P J Lachmann
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity.

Authors:  Nader Omidvar; Eddie C Y Wang; Paul Brennan; M Paula Longhi; Richard A G Smith; B Paul Morgan
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.